SCHWARTZ AHARON purchased 171.9% of their position (110K shares) of PROTALIX BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $155.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/5/2023ACC: 0001104659-23-001495
Director
Since Jan 2020
+110K
Net shares
Net buyer
$155.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
110K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+110K
Price / share
$1.42
Trade value
$155.81K
% of position
171.9%
1/3/2023
64K→174K
Total
Net shares
+110K
Net value
$155.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | P · Purchase | +110K | $1.42 | $155.81K | 171.9% | 64K | 174K |
| Total | +110K | $155.81K | ||||||
Derivative Transactions0
No derivative transactions reported